CN106605918A - Chewable tablets containing gamma-aminobutyric acid (GABA) and preparation method of chewable tablets - Google Patents
Chewable tablets containing gamma-aminobutyric acid (GABA) and preparation method of chewable tablets Download PDFInfo
- Publication number
- CN106605918A CN106605918A CN201510684509.7A CN201510684509A CN106605918A CN 106605918 A CN106605918 A CN 106605918A CN 201510684509 A CN201510684509 A CN 201510684509A CN 106605918 A CN106605918 A CN 106605918A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- lubricant
- formula
- gained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title claims abstract description 68
- 239000007910 chewable tablet Substances 0.000 title claims abstract description 35
- 229960003692 gamma aminobutyric acid Drugs 0.000 title claims abstract description 35
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims description 17
- 239000000843 powder Substances 0.000 claims abstract description 59
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 21
- 235000004936 Bromus mango Nutrition 0.000 claims abstract description 16
- 235000014826 Mangifera indica Nutrition 0.000 claims abstract description 16
- 235000009184 Spondias indica Nutrition 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 52
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 32
- 241001093152 Mangifera Species 0.000 claims description 28
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 26
- 229930003268 Vitamin C Natural products 0.000 claims description 26
- 235000019154 vitamin C Nutrition 0.000 claims description 26
- 239000011718 vitamin C Substances 0.000 claims description 26
- 239000011812 mixed powder Substances 0.000 claims description 24
- 229940068682 chewable tablet Drugs 0.000 claims description 23
- 239000000314 lubricant Substances 0.000 claims description 22
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 22
- 239000004386 Erythritol Substances 0.000 claims description 19
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 19
- 229940009714 erythritol Drugs 0.000 claims description 19
- 235000019414 erythritol Nutrition 0.000 claims description 19
- 238000002156 mixing Methods 0.000 claims description 19
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 18
- 229930182830 galactose Natural products 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 16
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 16
- 238000005469 granulation Methods 0.000 claims description 14
- 230000003179 granulation Effects 0.000 claims description 14
- 238000005303 weighing Methods 0.000 claims description 12
- 235000019359 magnesium stearate Nutrition 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 10
- 238000005550 wet granulation Methods 0.000 claims description 10
- 206010013786 Dry skin Diseases 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 229920001221 xylan Polymers 0.000 claims 2
- 150000004823 xylans Chemical class 0.000 claims 2
- 239000002023 wood Substances 0.000 claims 1
- 210000004556 brain Anatomy 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 235000009508 confectionery Nutrition 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 208000019901 Anxiety disease Diseases 0.000 abstract description 2
- 230000036506 anxiety Effects 0.000 abstract description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 abstract description 2
- 230000008451 emotion Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 240000007228 Mangifera indica Species 0.000 abstract 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 abstract 1
- 150000003271 galactooligosaccharides Chemical class 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 235000013339 cereals Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- 235000019614 sour taste Nutrition 0.000 description 7
- 235000019605 sweet taste sensations Nutrition 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000186016 Bifidobacterium bifidum Species 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 2
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 206010056474 Erythrosis Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 208000015634 Rectal Neoplasms Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- -1 carotene carotene Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 2
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 206010038038 rectal cancer Diseases 0.000 description 2
- 201000001275 rectum cancer Diseases 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000009633 chimonin Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000020845 low-calorie diet Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000001769 paralizing effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides chewable tablets containing gamma-aminobutyric acid (GABA). The chewable tablets are tabletting sweets made by using gamma-aminobutyric acid, dietary fiber powder, galactooligosaccharide, mango powder, apple powder, xylooligosaccharide and the like as raw materials, have the functions of resisting anxiety, regulating emotion, improving brain vitality, and reducing blood pressure, and are convenient to take and worth of popularization and application.
Description
Technical field
The present invention relates to a kind of chewable tablet containing γ-aminobutyric acid and preparation method thereof, belongs to field of health care food.
Background technology
γ-aminobutyric acid is the natural material extracted from the Testa oryzae rich in glutamic acid, is needed by human body nutritional labeling, is deposited
It is that in human body, long-term taking also will not product harmful effect.γ-aminobutyric acid（GABA）It is a kind of naturally occurring non-protein
Matter aminoacid, GABA is the important inhibitory neurotransmitter in central nervous system, with important physiological function, has been ground
The physiologically active for studying carefully report reduces blood pressure, promote ataraxy, promote brain blood flow, promote brain vigor, trophic nerve cell,
Increase growth hormone secretion, strong liver profit kidney, improve climacteric syndrome, senile dementia etc..
Food fibre powder adopts imported raw material --- and water soluble dietary fiber, the product, with native starch as raw material, is current
Unique a kind of water soluble dietary fiber used as raw-food material in the world, its fiber content is up to 85%-95%.The product is
Obtain U.S. FDA " popular safety and Health food（GRAS）" certification, and obtain Japanese " specific health food " certification.Meals are fine
Dimension belongs to low molecule water soluble dietary fiber, and dietary fiber is referred to as " the 7th nutrient " by nutrition educational circles, the appropriate meals of supplement
Fiber can effectively pre- preventing obesity, diabetes, coronary heart disease, rectal cancer, colon cancer etc., dietary fiber is by absorbing the water of stomach enteral
Point, rapid expansion makes human body produce satiety, and reduces intestinal absorption saccharide, lipid material, lubricates intestinal, promotes defecation,
Suppress fat.Dietary fiber can promote intestinal peristalsis promoting, soften stool, Constipation, colon cancer and rectal cancer；In reducing blood
Cholesterol, triglyceride, beneficial to obesity control；Remove the skin problems such as vivotoxin, prevention mottle formation, comedo；Reduce
Absorption of the saccharide in intestinal, reduces post-prandial glycemia；Promote intestinal beneficial bacterium propagation, improve absorption of human body ability.
Oligomeric galactose is described as third generation functional factor, is one of internationally recognized prebioticses, is confirmed as by U.S. FDA
GRAS materials, by Japanese legislative orientation health food.Oligomeric galactose can be utilized by the selective zymolysis of bacillus bifiduss, and with
The probioticss such as the bacillus bifiduss in 40 times of incremental speed propagation human body intestinal canals, suppress the generation of harmful bacteria, the micro- life of regulating intestinal canal
State is balanced, and generation is conducive to the health-care effect of host.Synthesis vitamin B group can be promoted, the absorption rate of protein is improved, promoted
Enter mineral absorption；Strengthen the colonization resistance and immunity of human body intestinal canal；Human body intestinal canal is promoted to wriggle.
The selected high-quality Fructus Mangifera Indicae generated under the nonpollution environment of Hainan, Jing special process processed was both remained
The local flavor fragrance of Fructus Mangifera Indicae itself, also saves the abundant nutritional labeling of Fructus Mangifera Indicae itself.Mango Fruit nutritive value is high, vitamin
A contents are up to 3.8%, and containing sugared 11-19%, protein 0.65-1.31%, crude fibre 14-24.8%, Fructus Mangifera Indicae contains abundant Hu Luo
Bu Su 22.81-63.04ug/g, and trace element needed by human（Selenium, calcium, phosphorus, potassium）Content is also very high.Fructus Mangifera Indicae can reduce gallbladder
Sterin, triglyceride, are conducive to placing cardiovascular disease.The carotene carotene content of Fructus Mangifera Indicae is especially high, is beneficial to vision, can moisten
Skin, is the good fruit of beauty of Ms.Contain chimonin in Fructus Mangifera Indicae, there is the work of obvious anti peroxidation of lipid and protection brain neuron
With energy delaying cell aging, raising brain function.It can significantly improve erythrocyte catalase vigor and reduce erythrocyte blood
Lactoferrin.
Fructus Mali pumilae, is not only the topmost fruit of China, is also to plant the most most fruit of wide, yield in the world.Its taste
Sour and sweet palatability, it is nutritious.According to surveying and determination, per 6.5-11.2 containing Fructose gram of hectogram Fructus Mali pumilae, 2.5-3.5 gram of glucose, sucrose 1.0-
5.2 gram；Spread a kind of saying in the U.S.：" regular meal eats a Fructus Mali pumilae, just without asking doctor ".Although this talks about some exaggerations, Herba Marsileae Quadrifoliae
Thus the nutrition of fruit and medical value can know something about.Again because the nutrition contained by Fructus Mali pumilae was not only comprehensive but also easily digested,
So, it is especially suitable for infant, old man and patients.
The fragrance of Fructus Mali pumilae is depressed and sense of depression the good medicine for the treatment of.Brainstrust finds through test of many times, in many abnormal smells from the patients
In, the fragrance of Fructus Mali pumilae is maximum to the psychological impact of people, and it has the effect for significantly eliminating psychological sense of depression.Clinical practice is demonstrate,proved
It is bright, allow depression patient to smell after Fructus Mali pumilae fragrance, mental state takes a favorable turn, spiritual relaxation and happiness, and sense of depression disappears.Experiment is also demonstrate,proved
Bright, insomniac smells apple aroma before sleep, can make one very fast quiet sleep.The element such as the phosphorus contained in Fructus Mali pumilae and ferrum, easily
Absorbed by intestinal wall, there is supplementing the brain blood-nourishing, tranquilizing effect.Contain more potassium in Fructus Mali pumilae, sodium salt that can be superfluous with human body is combined,
It is allowed to excrete.When human body intake sodium salt is excessive, a little Fructus Mali pumilaes are eaten, be conducive to balancing cylinder electrolyte.Cleaned with Fructus Mali pumilae and squeezed
Juice, each serving 100 milliliters, 3 times a day, continuously takes, and is within 15 days a course for the treatment of, and Fructus Mali pumilae has the effect for reducing cholesterol level；
Fructus Mali pumilae also has the double effects of relieving constipation and antidiarrheal and effect.
The oligomeric xylose that this product is obtained using corn cob enzyme process, oligomeric xylose is referred to as xylooligosaccharide, also known as " superpower bifid
The factor ", " oligomeric xylose " product is recommended as nutrient health and advocates product by national Public nutrition and centre of development, with usual people
Soybean oligo saccharide, oligofructose, oligomeric isomaltose used etc. are compared with unique advantage, and it can be selectively promoted
The proliferation activity of intestinal bifidobacteria.Its bifidobacterium factor functional is 10-20 times of other polymerization saccharides.Oligomeric xylose has suppression
Oral Pathogens and diarrhoea, the effects such as prevent constipation, the liver protecting function, reduce serum cholesterol, enhancing human body immunity power also
Body can be promoted to generate various nutrient substance, including vitamin B1, B2, B6, B12, nicotinic acid and Folic Acid.
Erythritol heat is extremely low, is diabeticss and the preferable low-calorie diet of high blood glucose person.This product is selected
" 0 card " sugar alcohol --- erythritol, is achieved the low heat value of product, meets the demand of more consumer groups.Erythritol exists
It is distributed in nature very extensively, not only has presence on a small quantity in tissue and body fluid, in being also present in some biologies, such as：Lichens
Class biology, bast-fibre biological, mushroom class biology etc., while in some fermented foods such as rice wine, medicated beer, bean milk, cheese, soy sauce all
There is the presence of erythritol.Erythritol adopts fermentative Production, and closer to natural conversion and extraction, erythritol is natural
The sweeting agent of zero calory, and impact of the erythritol to blood glucose is little, carbohydrate metabolism and change of blood sugar is not involved in, also with certain
Antioxidant activity.Erythritol is the hot highest of solution absorption, so its refrigerant sense is highest in sugar alcohol, is had after eating
Silk silk refrigerant sense.
A report of mechanism Datamonitor according to the study claims, and increasing consumer is look for the leisure of health
Food succedaneum.In the whole world, the consumer that there are about 42% starts to select healthy snack food.Meanwhile, survey data is displayed that, people
Sense of guilt is had when leisure food is eaten, therefore, low sugar, less salt, low fat, fibre rich, the healthy snack food of naturalization
To be praised highly by market.
The content of the invention
The present invention provides a kind of containing γ-aminobutyric acid chewable tablet and preparation method thereof, fine with γ-aminobutyric acid, meals
Dimension powder, oligomeric galactose, mango powder, apple powder, oligomeric xylose etc. are pressed candy made by raw material, with anxiety, are adjusted
Emotion；Improve brain vigor；The function of reducing blood pressure.Simultaneously chewable tablet tablet surface area increase Jing after chewing, can promote nutrition into
Divide dissolving in vivo and absorption.Taking convenience, can swallow, chew to contain and suck or take after water-dispersible.It is especially suitable old man, little
Child, paralytic, the patient for swallowing difficulty and gastrointestinal function difference.
What the present invention was provided is made up containing γ-aminobutyric acid formula of chewable tablets of the raw material of following percentage of weight parts：Red moss
Sugar alcohol 40-60 parts, apple powder 2-8 parts, mango powder 2-10 parts, oligomeric galactose 5-15 parts, water soluble dietary fiber 20-40 parts,
Oligomeric xylose 1-6 parts, essence 0.1-0.5 parts, γ-aminobutyric acid 0.01-0.1 part, vitamin C 0.1-0.5 parts, lubricant
0.5-1 parts.
The raw material containing γ-aminobutyric acid formula of chewable tablets percentage of weight part that the present invention is provided is preferably：Erythritol
40 parts, 8 parts of apple powder, 2 parts of mango powder, 15 parts of oligomeric galactose, 20 parts of water soluble dietary fiber, 6 parts of oligomeric xylose, essence
0.1 part, 0.1 part of γ-aminobutyric acid, 0.1 part of vitamin C, 1 part of lubricant.
The raw material containing γ-aminobutyric acid formula of chewable tablets percentage of weight part that the present invention is provided is also preferably：Erythrose
60 parts of alcohol, 2 parts of apple powder, 10 parts of mango powder, 5 parts of oligomeric galactose, 40 parts of water soluble dietary fiber, 1 part of oligomeric xylose, essence
0.5 part, 0.01 part of γ-aminobutyric acid, 0.5 part of vitamin C, 0.5 part of lubricant.
The raw material containing γ-aminobutyric acid formula of chewable tablets percentage of weight part that the present invention is provided is also preferably：Erythrose
48 parts of alcohol, 4 parts of apple powder, 6 parts of mango powder, 10 parts of oligomeric galactose, 28 parts of water soluble dietary fiber, 3 parts of oligomeric xylose, essence
0.25 part, 0.05 part of γ-aminobutyric acid, 0.3 part of vitamin C, 0.8 part of lubricant.
Essence of the present invention is preferably solid essence.
Solid essence of the present invention is preferably apple banana and/or Fructus Mangifera Indicae essence.
Lubricant of the present invention is preferably the conventional lubrication of the tablets such as magnesium stearate, micropowder silica gel, polyethylene glycol 6000
Agent.
Preparation method containing γ-aminobutyric acid chewable tablet of the present invention, comprises the following steps：
（1）Crush, weigh：Vitamin C is crushed, formula material sieves respectively, weighed respectively according to formula ratio, must be weighed
Powder, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to lubricant is mixed, and obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained, granulation is dried, and granulate obtains dry particl；
（4）Tabletting：By step（3）Gained dry particl, adds formula ratio lubricant, mixing, tabletting.
Preparation method containing γ-aminobutyric acid chewable tablet of the present invention, preferably：
（1）Crush, weigh：Vitamin C is crushed, by formula material, 50-80 mesh sieves is crossed respectively, weighed respectively according to formula ratio,
Powder must be weighed, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to lubricant is mixed, in putting mixer, 20-60 point of mixing
Clock, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 40-70 DEG C of drying, granulate obtains dry
Granule, it is standby；
（4）Tabletting：In step（3）The lubricant of formula ratio is added in gained dry particl, mixing 10-30 minutes in mixer are put,
Hybrid particles, tabletting are obtained, tablet format is 0.5-1g/ pieces.
Preparation method containing γ-aminobutyric acid chewable tablet of the present invention, also preferably：
（1）Crush, weigh：Vitamin C is crushed, formula material, 60 mesh sieves are crossed respectively, weighed respectively according to formula ratio, must be claimed
Amount powder, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to lubricant is mixed, and in putting mixer, is mixed 30 minutes,
Obtain total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, 50 DEG C of dryings, granulate, must do
Grain, it is standby；
（4）Tabletting：In step（3）The lubricant of formula ratio is added in gained dry particl, is put in mixer and is mixed 20 minutes, obtain mixed
Granule, tabletting are closed, piece weight-normality lattice are 0.7g/ pieces.
It is embodied as
Embodiment 1
Formula：
Erythritol 48g, apple powder 4g, mango powder 6g, oligomeric galactose 10g, water soluble dietary fiber 28g, oligomeric xylose 3g,
Apple essence 0.15g, Fructus Mangifera Indicae essence 0.1g, γ-aminobutyric acid 0.05g, vitamin C 0.3g, magnesium stearate 0.8g
Preparation method：
（（1）Crush, weigh：Vitamin C is crushed, formula material, 60 mesh sieves are crossed respectively, weighed respectively according to formula ratio, must be claimed
Amount powder, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to magnesium stearate is mixed, and in putting mixer, mixes 30 points
Clock, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, 50 DEG C of dryings, granulate, must do
Grain, it is standby；
（4）Tabletting：In step（3）The magnesium stearate of formula ratio is added in gained dry particl, is put in mixer and is mixed 20 minutes, obtained
Hybrid particles, tabletting, piece weight-normality lattice are 0.7g/ pieces.
Embodiment 2
Formula：
Erythritol 40g, apple powder 8g, mango powder 2g, oligomeric galactose 15g, water soluble dietary fiber 20g, oligomeric xylose 6g,
Apple essence 0.1g, γ-aminobutyric acid 0.1g, vitamin C 0.1g, magnesium stearate 1g.
Preparation method：
（1）Crush, weigh：Vitamin C is crushed, by formula material, 40 mesh sieves is crossed respectively, weighed respectively according to formula ratio, obtained
Powder is weighed, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to profit magnesium stearate is mixed, and in putting mixer, mixes 60 points
Clock, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, 70 DEG C of dryings, granulate, must do
Grain, it is standby；
（4）Tabletting：In step（3）The magnesium stearate of formula ratio is added in gained dry particl, is put in mixer and is mixed 30 minutes, obtained
Hybrid particles, tabletting, piece weight-normality lattice are 0.5g/ pieces.
Embodiment 3
Formula：
Erythritol 60g, apple powder 2g, mango powder 10g, oligomeric galactose 5g, water soluble dietary fiber 40g, oligomeric xylose 1g,
Fructus Mangifera Indicae essence 0.5g, γ-aminobutyric acid 0.01g, vitamin C 0.5g, magnesium stearate 0.5g.
Preparation method：
（1）Crush, weigh：Vitamin C is crushed, by formula material, 50 mesh sieves is crossed respectively, weighed respectively according to formula ratio, obtained
Powder is weighed, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to magnesium stearate is mixed, and in putting mixer, mixes 20 points
Clock, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, 40 DEG C of dryings, granulate, must do
Grain, it is standby；
（4）Tabletting：In step（3）The magnesium stearate of formula ratio is added in gained dry particl, is put in mixer and is mixed 10 minutes, obtained
Hybrid particles, tabletting, piece weight-normality lattice are 1g/ pieces.
Embodiment 4
Formula：
Erythritol 55g, apple powder 3g, mango powder 7g, oligomeric galactose 8g, water soluble dietary fiber 22g, oligomeric xylose 5g,
Fructus Mangifera Indicae essence 0.15g, γ-aminobutyric acid 0.08g, vitamin C 0.4g, micropowder silica gel 0.7g.
Preparation method：
（1）Crush, weigh：Vitamin C is crushed, by formula material, 80 mesh sieves is crossed respectively, weighed respectively according to formula ratio, obtained
Powder is weighed, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to micropowder silica gel is mixed, and in putting mixer, mixes 20 points
Clock, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, 50 DEG C of dryings, granulate, must do
Grain, it is standby；
（4）Tabletting：In step（3）The micropowder silica gel of formula ratio is added in gained dry particl, is put in mixer and is mixed 30 minutes, obtained
Hybrid particles, tabletting, piece weight-normality lattice are 0.8g/ pieces.
Embodiment 5
Formula：
Erythritol 53g, apple powder 3g, mango powder 3g, oligomeric galactose 12g, water soluble dietary fiber 33g, oligomeric xylose 2g,
Fructus Mangifera Indicae essence 0.2g, γ-aminobutyric acid 0.03g, vitamin C 0.2g, micropowder silica gel 0.6g.
Preparation method：
（1）Crush, weigh：Vitamin C is crushed, by formula material, 20 mesh sieves is crossed respectively, weighed respectively according to formula ratio, obtained
Powder is weighed, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to micropowder silica gel is mixed, and in putting mixer, mixes 60 points
Clock, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, 70 DEG C of dryings, granulate, must do
Grain, it is standby；
（4）Tabletting：In step（3）The micropowder silica gel of formula ratio is added in gained dry particl, is put in mixer and is mixed 10 minutes, obtained
Hybrid particles, tabletting, piece weight-normality lattice are 0.6g/ pieces.
Embodiment 6
Formula：
Erythritol 46g, apple powder 7g, mango powder 3g, oligomeric galactose 6g, water soluble dietary fiber 34g, oligomeric xylose 5g,
Apple essence 0.4g, γ-aminobutyric acid 0.03g, vitamin C 0.4g, polyethylene glycol 6000 0.7g.
Preparation method：
（1）Crush, weigh：Vitamin C is crushed, by formula material, 80 mesh sieves is crossed respectively, weighed respectively according to formula ratio, obtained
Powder is weighed, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to polyethylene glycol 6000 is mixed, in putting mixer, mixing 40
Minute, obtain total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, 60 DEG C of dryings, granulate, must do
Grain, it is standby；
（4）Tabletting：In step（3）The polyethylene glycol 6000 of formula ratio is added in gained dry particl, is put and mix in mixer 10 points
Clock, obtains hybrid particles, tabletting, and piece weight-normality lattice are 0.9g/ pieces.
Test example：In order to identify the performance of chewable tablet, the evaluation group of 15 people is constituted by professional, with the hard of chewable tablet
Degree, outward appearance, mouthfeel are index, and the chewable tablet of above example is scored respectively, and 10 points is full marks, illustrates the property of chewable tablet
Can preferably, test concrete outcome is as follows：
| Outward appearance | Mouthfeel | Hardness（kg/cm2） | Scoring | |
| Embodiment 1 | Surface is complete, bright and clean | Tasty and refreshing, fine and smooth, sweet and sour taste, free from extraneous odour | 4.8 | 9.0 |
| Embodiment 2 | Surface is complete, bright and clean | Tasty and refreshing, fine and smooth, sweet and sour taste, free from extraneous odour | 5.3 | 9.5 |
| Embodiment 3 | Surface is complete, bright and clean | Tasty and refreshing, fine and smooth, sweet and sour taste, free from extraneous odour | 5.1 | 9.1 |
| Embodiment 4 | Surface is complete, bright and clean | Tasty and refreshing, fine and smooth, sweet and sour taste, free from extraneous odour | 5.2 | 9.3 |
| Embodiment 5 | Surface is complete, bright and clean | Tasty and refreshing, fine and smooth, sweet and sour taste, free from extraneous odour | 5.5 | 8.7 |
| Embodiment 6 | Surface is complete, bright and clean | Tasty and refreshing, fine and smooth, sweet and sour taste, free from extraneous odour | 5.2 | 9.1 |
From above result of the test, the chewable tablet prepared using the formula and preparation method thereof of embodiment 1-6, the complete light in surface
Sliding, mouthfeel is tasty and refreshing, fine and smooth, sweet and sour taste, and free from extraneous odour, hardness is suitable, and expert analysis mode is illustrated using we more than 8.5 points
Chewable tablet better performances prepared by face method, are suitable for industrialized great production.
Claims (10)
1. a kind of chewable tablet containing γ-aminobutyric acid, it is characterised in that the formula of chewable tablets is by following percentage of weight parts
Raw material is made：Erythritol 40-60 parts, apple powder 2-8 parts, mango powder 2-10 parts, oligomeric galactose 5-15 parts, aqueous soluble dietary
Fiber 20-40 parts, oligomeric xylose 1-6 parts, essence 0.1-0.5 parts, γ-aminobutyric acid 0.01-0.1 part, vitamin C 0.1-0.5
Part, lubricant 0.5-1 parts.
2. chewable tablet according to claim 1, it is characterised in that the formula of chewable tablets by following percentage of weight parts original
Material is made：It is 40 parts of erythritol, 8 parts of apple powder, 2 parts of mango powder, 15 parts of oligomeric galactose, 20 parts of water soluble dietary fiber, low
6 parts of xylan, 0.1 part of essence, 0.1 part of γ-aminobutyric acid, 0.1 part of vitamin C, 1 part of lubricant.
3. chewable tablet according to claim 1, it is characterised in that the formula of chewable tablets by following percentage of weight parts original
Material is made：It is 60 parts of erythritol, 2 parts of apple powder, 10 parts of mango powder, 5 parts of oligomeric galactose, 40 parts of water soluble dietary fiber, low
1 part of xylan, 0.5 part of essence, 0.01 part of γ-aminobutyric acid, 0.5 part of vitamin C, 0.5 part of lubricant.
4. chewable tablet according to claim 1, it is characterised in that formula of chewable tablets by following percentage of weight parts raw material system
Into：48 parts of erythritol, 4 parts of apple powder, 6 parts of mango powder, 10 parts of oligomeric galactose, 28 parts of water soluble dietary fiber, oligomeric wood
3 parts of sugar, 0.25 part of essence, 0.05 part of γ-aminobutyric acid, 0.3 part of vitamin C, 0.8 part of lubricant.
5. the chewable tablet according to any one of claim 1-4, it is characterised in that the essence is solid essence.
6. chewable tablet according to claim 5, it is characterised in that the solid essence is that apple essence and/or Fructus Mangifera Indicae are fragrant
Essence.
7. the chewable tablet according to any one of claim 1-4, it is characterised in that the lubricant is magnesium stearate.
8. the preparation method of the chewable tablet according to any one of claim 1-4, it is characterised in that comprise the following steps：
（1）Crush, weigh：Vitamin C is crushed, formula material sieves respectively, weighed respectively according to formula ratio, must be weighed
Powder, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to lubricant is mixed, and obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained, granulation is dried, and granulate obtains dry particl；
（4）Tabletting：By step（3）Gained dry particl, adds formula ratio lubricant, mixing, tabletting.
9. the preparation method of chewable tablet according to claim 8, it is characterised in that comprise the following steps：
（1）Crush, weigh：Vitamin C is crushed, by formula material, 20-80 mesh sieves is crossed respectively, weighed respectively according to formula ratio,
Powder must be weighed, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to lubricant is mixed, in putting mixer, 20-60 point of mixing
Clock, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 40-70 DEG C of drying, granulate obtains dry
Granule, it is standby；
（4）Tabletting：In step（3）The lubricant of formula ratio is added in gained dry particl, mixing 10-30 minutes in mixer are put,
Hybrid particles, tabletting are obtained, tablet format is 0.5-1g/ pieces.
10. the preparation method of chewable tablet according to claim 9, it is characterised in that comprise the following steps：
（1）Crush, weigh：Vitamin C is crushed, formula material, 60 mesh sieves are crossed respectively, weighed respectively according to formula ratio, must be claimed
Amount powder, it is standby；
（2）Mixing：By step（1）Weighing powder of the gained in addition to lubricant is mixed, and in putting mixer, is mixed 30 minutes,
Obtain total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, 50 DEG C of dryings, granulate, must do
Grain, it is standby；
（4）Tabletting：In step（3）The lubricant of formula ratio is added in gained dry particl, is put in mixer and is mixed 20 minutes, obtain mixed
Granule, tabletting are closed, piece weight-normality lattice are 0.7g/ pieces.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510684509.7A CN106605918A (en) | 2015-10-22 | 2015-10-22 | Chewable tablets containing gamma-aminobutyric acid (GABA) and preparation method of chewable tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510684509.7A CN106605918A (en) | 2015-10-22 | 2015-10-22 | Chewable tablets containing gamma-aminobutyric acid (GABA) and preparation method of chewable tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106605918A true CN106605918A (en) | 2017-05-03 |
Family
ID=58610325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510684509.7A Pending CN106605918A (en) | 2015-10-22 | 2015-10-22 | Chewable tablets containing gamma-aminobutyric acid (GABA) and preparation method of chewable tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106605918A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107156411A (en) * | 2017-05-10 | 2017-09-15 | 苏州工业园区尚融科技有限公司 | It is a kind of to improve the tasty and refreshing sugar of sugar-free of immune function of human body |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103385471A (en) * | 2013-07-10 | 2013-11-13 | 山东禹城禹王生态食业有限公司 | Nutrition and healthcare double-protein chewing tablet and preparation method thereof |
-
2015
- 2015-10-22 CN CN201510684509.7A patent/CN106605918A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103385471A (en) * | 2013-07-10 | 2013-11-13 | 山东禹城禹王生态食业有限公司 | Nutrition and healthcare double-protein chewing tablet and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107156411A (en) * | 2017-05-10 | 2017-09-15 | 苏州工业园区尚融科技有限公司 | It is a kind of to improve the tasty and refreshing sugar of sugar-free of immune function of human body |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104643250B (en) | It is a kind of can bidirectional modulation body weight improve inferior health solid beverage | |
| CN102224891B (en) | Sugar alcohol honey apple jam and preparation method thereof | |
| CN106509856A (en) | Chewing tablet containing collagen and preparation method thereof | |
| CN106605904A (en) | Chewable tablets containing acerola cherry powder and preparation method of chewable tablets | |
| CN102511861A (en) | Thickened red jujube pulp added with oligosaccharide | |
| CN104664370A (en) | Chewable flax tablet | |
| CN105379927A (en) | Low-calorie sugar-free hard candy containing meso-erythritol and preparation method thereof | |
| CN102511864B (en) | Jujube high-consistency stock | |
| CN107455625A (en) | A kind of nutrient for plants beverage and its preparation technology with antifatigue weight losing function | |
| CN103371318B (en) | Dietary nutrition replenishing food | |
| CN102090563B (en) | Relaxing and sleeping health-care food and preparation method thereof | |
| CN102919648B (en) | Nutrient and health-care highland barley jelly and preparation method thereof | |
| CN106387900A (en) | Composition for regulating blood lipid, blood pressure and blood sugar, as well as application thereof | |
| CN105341300A (en) | Health-care candies suitable for children to eat | |
| CN107410631A (en) | A kind of multi-functional glycoconjugate and preparation method and application | |
| CN106605918A (en) | Chewable tablets containing gamma-aminobutyric acid (GABA) and preparation method of chewable tablets | |
| CN102048134A (en) | Five-material vegetable nutraceutical and preparation method thereof | |
| CN106509589A (en) | Chewing tablet containing xanthophyll and preparation method thereof | |
| CN108634177A (en) | A kind of health type high protein rice flour | |
| CN107439866A (en) | Matrimony vine chickpea plant nutrients beverage and its preparation technology | |
| CN105087284B (en) | A kind of compound raspberry health preserving wine and preparation method thereof | |
| CN102511870A (en) | Thickened red jujube pulp beneficial to losing weight | |
| CN102511860B (en) | Thickened red jujube pulp added with phytosterin and being suitable for being taken by pregnant women | |
| CN106262882A (en) | Tremella sweet potato flour instant food and preparation method thereof | |
| CN102885364A (en) | Corn beverage and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170503 |